Christel Fontaine

2.1k total citations · 1 hit paper
73 papers, 1.5k citations indexed

About

Christel Fontaine is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christel Fontaine has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christel Fontaine's work include Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (12 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Christel Fontaine is often cited by papers focused on Cancer Treatment and Pharmacology (21 papers), Breast Cancer Treatment Studies (12 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Christel Fontaine collaborates with scholars based in Belgium, United States and Netherlands. Christel Fontaine's co-authors include Jacques De Grève, Jan Lamote, Marian Vanhoeij, Hendrik Everaert, Denis Schallier, Vicky Caveliers, Tony Lahoutte, Marleen Keyaerts, Ilse Vaneycken and Nick Devoogdt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Christel Fontaine

69 papers receiving 1.4k citations

Hit Papers

Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
    2015 341 citations Marleen Keyaerts, Catarina Xavier et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christel Fontaine Belgium 18 687 494 408 356 174 73 1.5k
Jan Lamote Belgium 21 627 0.9× 424 0.9× 178 0.4× 295 0.8× 302 1.7× 74 1.5k
Cliona Kirwan United Kingdom 22 529 0.8× 165 0.3× 233 0.6× 180 0.5× 549 3.2× 94 1.6k
Alessandra Felici Italy 19 485 0.7× 111 0.2× 293 0.7× 361 1.0× 193 1.1× 49 1.1k
Christoph Salat Germany 22 564 0.8× 148 0.3× 470 1.2× 346 1.0× 336 1.9× 63 2.0k
Darrell D. Davidson United States 29 792 1.2× 158 0.3× 577 1.4× 736 2.1× 326 1.9× 82 2.5k
Florian Clatot France 24 692 1.0× 99 0.2× 321 0.8× 401 1.1× 461 2.6× 99 1.6k
Enrique González‐Billalabeitia Spain 19 580 0.8× 61 0.1× 527 1.3× 365 1.0× 399 2.3× 75 1.3k
Charles Cha United States 24 973 1.4× 148 0.3× 562 1.4× 692 1.9× 391 2.2× 79 2.5k
Ewa Sierko Poland 20 662 1.0× 86 0.2× 475 1.2× 305 0.9× 405 2.3× 81 1.6k
Saad A. Khan United States 20 840 1.2× 119 0.2× 220 0.5× 412 1.2× 192 1.1× 89 1.4k

Countries citing papers authored by Christel Fontaine

Since Specialization
Citations

This map shows the geographic impact of Christel Fontaine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christel Fontaine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christel Fontaine more than expected).

Fields of papers citing papers by Christel Fontaine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christel Fontaine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christel Fontaine. The network helps show where Christel Fontaine may publish in the future.

Co-authorship network of co-authors of Christel Fontaine

This figure shows the co-authorship network connecting the top 25 collaborators of Christel Fontaine. A scholar is included among the top collaborators of Christel Fontaine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christel Fontaine. Christel Fontaine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lahousse, Astrid, Jo Nijs, David Beckwée, et al.. (2024). The effect of pain neuroscience education and behavioural graded activity in breast cancer survivors: a randomised controlled multi-center trial. European Journal of Cancer. 200. 113606–113606. 1 indexed citations
3.
4.
Roose, Eva, Wilfried Cools, Laurence Leysen, et al.. (2024). Psychological factors influencing healthcare utilization in breast cancer survivors with pain. Pain Medicine. 25(12). 768–780.
5.
Xavier, Catarina, Johannes Heemskerk, Nick Devoogdt, et al.. (2023). Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I). Journal of Nuclear Medicine. 64(9). 1378–1384. 26 indexed citations
6.
Agostinetto, Elisa, Guilherme Nader Marta, Marianne Paesmans, et al.. (2022). ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast. Future Oncology. 18(22). 2383–2392. 15 indexed citations
7.
Carey, Lisa A., Delphine Loirat, Kevin Punie, et al.. (2022). Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis. npj Breast Cancer. 8(1). 72–72. 37 indexed citations
8.
Vinh‐Hung, Vincent, Hendrik Everaert, Hilde Van Parijs, et al.. (2021). Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratio. Breast Cancer. 28(4). 956–968. 4 indexed citations
9.
Carey, Lisa A., Delphine Loirat, Kevin Punie, et al.. (2021). Assessment of sacituzumab govitecan (SG) in patients with prior neoadjuvant/adjuvant chemotherapy in the phase 3 ASCENT study in metastatic triple-negative breast cancer (mTNBC).. Journal of Clinical Oncology. 39(15_suppl). 1080–1080. 5 indexed citations
10.
D’Huyvetter, Matthias, Jens De Vos, Vicky Caveliers, et al.. (2020). Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients. Journal of Nuclear Medicine. 62(8). 1097–1105. 90 indexed citations
11.
12.
Claes, Nerée, Patrizio Mazza, Bogdan Żurawski, et al.. (2016). Use of lipegfilgrastim in clinical practice for the prophylaxis of chemotherapy-induced neutropenia: interim results of pan-European non-interventional study. Annals of Oncology. 27. vi505–vi505. 2 indexed citations
13.
Vinh‐Hung, Vincent, Hendrik Everaert, Jan Lamote, et al.. (2012). Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 39(10). 1618–1627. 11 indexed citations
14.
Fontaine, Christel, et al.. (2011). Evaluation of a Comprehensive Rehabilitation Program for Post-Treatment Patients With Cancer. Oncology nursing forum. 38(6). E418–E424. 16 indexed citations
15.
Wildiers, Hans, Christel Fontaine, Peter Vuylsteke, et al.. (2010). Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 123(2). 463–469. 39 indexed citations
16.
Trullemans, Fabienne, et al.. (2009). 1253 Tyrosine kinase inhibitor (TKI)-induced macrocytosis. European Journal of Cancer Supplements. 7(2). 136–136. 1 indexed citations
17.
Fontaine, Christel, Ann Meulemans, Manon Huizing, et al.. (2008). Tolerance of adjuvant letrozole outside of clinical trials. The Breast. 17(4). 376–381. 41 indexed citations
18.
Neyns, Bart, Yves Van Nieuwenhove, Maridi Aerts, et al.. (2006). Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.. PubMed. 26(1B). 611–9. 21 indexed citations
19.
Neyns, Bart, Yves Van Nieuwenhove, Christel Fontaine, et al.. (2004). A feasibility study on hepatic arterial infusion (HAI) of oxaliplatin followed by I-folinic acid modulated continuous HAI of 5-fluorouracil as second line chemotherapy for stage IV colorectal cancer limited to the liver. Ghent University Academic Bibliography (Ghent University). 2 indexed citations
20.
Fontaine, Christel, et al.. (1981). [Arterial vascularization of the tail of the pancreas].. PubMed. 65(188). 93–100. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Lamote Breakdown of academic impact, for papers by Cliona Kirwan Breakdown of academic impact, for papers by Alessandra Felici Breakdown of academic impact, for papers by Christoph Salat Breakdown of academic impact, for papers by Darrell D. Davidson Breakdown of academic impact, for papers by Florian Clatot Breakdown of academic impact, for papers by Enrique González‐Billalabeitia Breakdown of academic impact, for papers by Charles Cha Breakdown of academic impact, for papers by Ewa Sierko Breakdown of academic impact, for papers by Saad A. Khan
Rankless by CCL
2026